2024 |
Johnson & Johnson
|
Chairman of the Board and Chief Executive Officer |
24.3 M |
-14.4 % |
2023 |
Johnson & Johnson
|
Chairman of the Board and Chief Executive Officer |
28.4 M |
116.8 % |
2022 |
Johnson & Johnson
|
Chairman of the Board and Chief Executive Officer |
13.1 M |
-5.1 % |
2021 |
Johnson & Johnson
|
- |
13.8 M |
-11.6 % |
2021 |
Johnson & Johnson
|
Director and Chief Executive Officer |
13.8 M |
-11.6 % |
2020 |
Johnson & Johnson
|
- |
15.6 M |
16.4 % |
2020 |
Johnson & Johnson
|
Vice Chairman |
15.6 M |
16.4 % |
2020 |
Johnson & Johnson
|
- |
15.6 M |
16.4 % |
2019 |
Johnson & Johnson
|
- |
13.4 M |
44.5 % |
2019 |
Johnson & Johnson
|
- |
13.4 M |
44.5 % |
2019 |
Johnson & Johnson
|
Vice Chairman |
13.4 M |
44.5 % |
2018 |
Johnson & Johnson
|
- |
9.3 M |
-52.0 % |
2018 |
Johnson & Johnson
|
- |
9.3 M |
-52.0 % |
2018 |
Johnson & Johnson
|
Vice Chairman |
9.3 M |
-52.0 % |
2017 |
Johnson & Johnson
|
- |
19.4 M |
91.6 % |
2017 |
Johnson & Johnson
|
- |
19.4 M |
91.6 % |
2017 |
Johnson & Johnson
|
Executive Vice President and Worldwide Chairman, Pharmaceuticals |
19.4 M |
91.6 % |
2016 |
Johnson & Johnson
|
- |
10.1 M |
- |
2016 |
Johnson & Johnson
|
- |
10.1 M |
- |
2016 |
Johnson & Johnson
|
Executive Vice President and Worldwide Chairman, Pharmaceuticals |
10.1 M |
- |